Theravance Biopharma, Inc.
TBPH
Revenue
18.75M
▲1.89M▲11.18%
3 Months ChangeAssets
354.16M
▼-1.94M▼-0.5459%
3 Months ChangeLiabilities
178.62M
▲8.17M▲4.79%
3 Months ChangeFree Cash Flow
-1.11M
▲11.05M▲90.85%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-23
Form 8-K
ID: 0001104659-24-101816
2024-09-10
Form 8-K
ID: 0001104659-24-098326
2024-08-08
Form 10-Q
ID: 0001558370-24-011636
2024-08-05
Form 8-K
ID: 0001104659-24-085826
2024-05-15
Form 10-Q
ID: 0001558370-24-008201
2024-05-13
Form 8-K
ID: 0001104659-24-060536
2024-05-09
Form 8-K
ID: 0001104659-24-059338
2024-02-28
Form 8-K
ID: 0001104659-24-028809
2024-02-26
Form 8-K
ID: 0001104659-24-027510
2024-01-16
Form 8-K
ID: 0001104659-24-003852